Abstract:Single-cell molecular tools have been developed at an incredible pace over the last five years as sequencing costs continue to drop and numerous molecular assays have been coupled to sequencing readouts. This rapid period of technological development has facilitated the delineation of individual molecular characteristics including the genome, transcriptome, epigenome, and proteome of individual cells, leading to an unprecedented resolution of the molecular networks governing complex biological systems. The immense power of single-cell molecular screens has been particularly highlighted through work in systems where cellular heterogeneity is a key feature, such as stem cell biology, immunology, and tumor cell biology. Single-cell-omics technologies have already contributed to the identification of novel disease biomarkers, cellular subsets, therapeutic targets and diagnostics, many of which would have been undetectable by bulk sequencing approaches. More recently, efforts to integrate single-cell multi-omics with single cell functional output and/or physical location have been challenging but have led to substantial advances. Perhaps most excitingly, there are emerging opportunities to reach beyond the description of static cellular states with recent advances in modulation of cells through CRISPR technology, in particular with the development of base editors which greatly raises the prospect of cell and gene therapies. In this review, we provide a brief overview of emerging single-cell technologies and discuss current developments in integrating single-cell molecular screens and performing single-cell multi-omics for clinical applications. We also discuss how single-cell molecular assays can be usefully combined with functional data to unpick the mechanism of cellular decision-making. Finally, we reflect upon the introduction of spatial transcriptomics and proteomics, its complementary role with single-cell RNA sequencing (scRNA-seq) and potential application in cellular and gene therapy.

Single cell screening approaches for antibody discovery

Single B cell technologies for monoclonal antibody discovery

High-throughput single-cell screening of viable hybridomas and patient-derived antibody-secreting cells using punchable microwells

Application of Microfluidic Technology in Antibody Screening

High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics

An Automated Single‐Cell Droplet‐Digital Microfluidic Platform for Monoclonal Antibody Discovery

Monoclonal antibodies: technologies for early discovery and engineering

A Generic Approach for Miniaturized Unbiased High-Throughput Screens of Bispecific Antibodies and Biparatopic Antibody–Drug Conjugates

Miniaturized single-cell technologies for monoclonal antibody discovery

Discovery of antibodies targeting multipass transmembrane proteins using a suspension cell-based evolutionary approach

Interactive design and validation of antibody panels using single-cell RNA-seq atlases

New Horizons in Therapeutic Antibody Discovery: Opportunities and Challenges versus Small-Molecule Therapeutics

Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assays.

A new generation of nanobody research tools using improved mass spectrometry-based discovery methods

Exploiting Single-Cell Tools in Gene and Cell Therapy

A high throughput bispecific antibody discovery pipeline

Methods and applications of antibody microarrays in cancer research

Automated High-Throughput Flow Cytometry for High-Content Screening in Antibody Development

A High-Throughput Single-Cell Assay on a Valve-Based Microfluidic Platform Applied to Protein Quantification, Immune Response Monitoring, and Drug Discovery

Nanobody Technology: A Versatile Toolkit for Microscopic Imaging, Protein–Protein Interaction Analysis, and Protein Function Exploration

Functional single-cell hybridoma screening using droplet-based microfluidics